A patient has non-Hodgkin's lymphoma (NHL). When reviewing the history, which finding is a risk factor for NHL?

The Nightingale Pathophysiology Test is your destination for mastering complex medical concepts. Utilize multiple choice questions and flashcards, all with detailed explanations. Enhance your understanding and boost your confidence. Prepare effectively for your exam!

Multiple Choice

A patient has non-Hodgkin's lymphoma (NHL). When reviewing the history, which finding is a risk factor for NHL?

Explanation:
Immunosuppression after organ transplantation increases the risk of non-Hodgkin lymphoma because the immune system’s ability to detect and control abnormal B cells is diminished. With ongoing immunosuppressive therapy, T-cell surveillance wanes, allowing latent Epstein-Barr virus–driven B cells to proliferate unchecked and potentially transform into B-cell lymphomas. This risk, known as post-transplant lymphoproliferative disorder, can emerge years after the transplant and is a recognized association with NHL. Regular exercise tends to support immune health and is not a known risk factor for NHL. Vitamin D deficiency and a low-sodium diet are not established NHL risk factors, making the history finding of an organ transplant the most relevant in increasing NHL risk.

Immunosuppression after organ transplantation increases the risk of non-Hodgkin lymphoma because the immune system’s ability to detect and control abnormal B cells is diminished. With ongoing immunosuppressive therapy, T-cell surveillance wanes, allowing latent Epstein-Barr virus–driven B cells to proliferate unchecked and potentially transform into B-cell lymphomas. This risk, known as post-transplant lymphoproliferative disorder, can emerge years after the transplant and is a recognized association with NHL.

Regular exercise tends to support immune health and is not a known risk factor for NHL. Vitamin D deficiency and a low-sodium diet are not established NHL risk factors, making the history finding of an organ transplant the most relevant in increasing NHL risk.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy